Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Outset Medical Inc’s stock clocked out at $3.97, down -5.02% from its previous closing price of $4.18. In other words, the price has decreased by -$5.02 from its previous closing price. On the day, 0.57 million shares were traded. OM stock price reached its highest trading level at $4.25 during the session, while it also had its lowest trading level at $3.94.
Ratios:
To gain a deeper understanding of OM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.77 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.68.
Upgrades & Downgrades
In the most recent recommendation for the company, RBC Capital Mkts on August 08, 2024, Downgraded its rating to Sector Perform and sets its target price to $3 from $6 previously.
On June 21, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $5 to $6.
On April 08, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on April 08, 2024, with a $6 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 01 ’25 when Drexler Karen sold 1,548 shares for $4.37 per share. The transaction valued at 6,765 led to the insider holds 10,650 shares of the business.
Trigg Leslie sold 916 shares of OM for $4,214 on Nov 17 ’25. The Chair and CEO now owns 121,412 shares after completing the transaction at $4.60 per share. On Nov 17 ’25, another insider, Nash Marc, who serves as the EVP Operations R&D & Service of the company, sold 247 shares for $4.60 each. As a result, the insider received 1,136 and left with 48,268 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 72067768 and an Enterprise Value of -4049232. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.60 while its Price-to-Book (P/B) ratio in mrq is 0.51. Its current Enterprise Value per Revenue stands at -0.034 whereas that against EBITDA is 0.063.
Stock Price History:
The Beta on a monthly basis for OM is 2.06, which has changed by -0.7240924 over the last 52 weeks, in comparison to a change of 0.12838376 over the same period for the S&P500. Over the past 52 weeks, OM has reached a high of $25.35, while it has fallen to a 52-week low of $4.00. The 50-Day Moving Average of the stock is -57.48%, while the 200-Day Moving Average is calculated to be -70.40%.
Shares Statistics:
It appears that OM traded 456.28K shares on average per day over the past three months and 513420 shares per day over the past ten days. A total of 17.81M shares are outstanding, with a floating share count of 17.39M. Insiders hold about 4.18% of the company’s shares, while institutions hold 98.80% stake in the company. Shares short for OM as of 1764288000 were 2118659 with a Short Ratio of 4.64, compared to 1761868800 on 1728691. Therefore, it implies a Short% of Shares Outstanding of 2118659 and a Short% of Float of 11.799999999999999.
Earnings Estimates
The market rating for Outset Medical Inc (OM) is a result of the insights provided by 4.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.76, with high estimates of -$0.71 and low estimates of -$0.8.
Analysts are recommending an EPS of between -$3.86 and -$5.45 for the fiscal current year, implying an average EPS of -$4.46. EPS for the following year is -$2.66, with 4.0 analysts recommending between -$2.02 and -$3.19.
Revenue Estimates
In. The current quarter, 4 analysts expect revenue to total $26.15M. It ranges from a high estimate of $26.9M to a low estimate of $24.9M. As of. The current estimate, Outset Medical Inc’s year-ago sales were $29.47MFor the next quarter, 4 analysts are estimating revenue of $29.22M. There is a high estimate of $30.9M for the next quarter, whereas the lowest estimate is $28.3M.
A total of 4 analysts have provided revenue estimates for OM’s current fiscal year. The highest revenue estimate was $117.5M, while the lowest revenue estimate was $115.5M, resulting in an average revenue estimate of $116.75M. In the same quarter a year ago, actual revenue was $113.69MBased on 4 analysts’ estimates, the company’s revenue will be $127.39M in the next fiscal year. The high estimate is $130M and the low estimate is $124.26M.
